ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 Nuclear Energy Conference & Expo (NECX)
August 24–27, 2026
Dallas, TX|Hilton Anatole
Latest Magazine Issues
Aug 2026
Jan 2026
2026
Latest Journal Issues
Nuclear Science and Engineering
October 2026
Nuclear Technology
September 2026
Fusion Science and Technology
August 2026
Latest News
Second round of Launch Pad selections includes eight newcomers
The National Reactor Innovation Center at Idaho National Laboratory has announced 13 project selections across 12 companies for the Nuclear Energy Launch Pad, a Department of Energy–led program that integrates reactor and fuel facility authorization, testing, and deployment support for private nuclear developers.
The Launch Pad emerged from the Reactor Pilot Program and Fuel Line Pilot Program.
According to INL, projects selected include reactor development and nuclear fuel cycle advancements, including fabrication, enrichment, and conversion technologies.
Thomas R. Jarboe
Fusion Science and Technology | Volume 36 | Number 1 | July 1999 | Pages 85-91
Technical Paper | doi.org/10.13182/FST99-A94
Articles are hosted by Taylor and Francis Online.
A steady inductive helicity injection (SIHI) method is described that has the following properties: (a) helicity is injected at a nearly constant rate; (b) neither magnetic energy nor helicity flow out of plasma at any time; (c) no open field lines penetrate the walls; (d) the equilibrium is produced in a close-fitting flux conserver; (e) a rotating magnetic structure is produced directly; and (f) in the frame of the rotating field, the current profile is nearly time independent and nearly optimum for the application discussed. SIHI can be applied to any toroidal plasma. Application of SIHI to a high-beta spheromak is described.